Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Therapy-Related Myeloid Neoplasm: A Study from the Chronic Malignancies Working Party of the EBMT
Academic Article
Publication Date:
2019
abstract:
DISCLOSURES: Robin: Novartis Neovii: Research Funding. Beelen:Medac GmbH Wedel Germany: Consultancy, Honoraria. Kroeger:DKMS: Research Funding; Neovii: Honoraria, Research Funding; Celgene: Honoraria, Research Funding; Riemser: Research Funding; JAZZ: Honoraria; Sanofi-Aventis: Honoraria; Novartis: Honoraria, Research Funding; Medac: Honoraria. Platzbecker:Celgene: Consultancy, Honoraria, Research Funding; Novartis: Consultancy, Honoraria, Research Funding; Abbvie: Consultancy, Honoraria. Finke:Riemser: Honoraria, Other: research support, Speakers Bureau; Neovii: Honoraria, Other: research support, Speakers Bureau; Medac: Honoraria, Other: research support, Speakers Bureau. Blaise:Pierre Fabre medicaments: Honoraria; Molmed: Consultancy, Honoraria; Sanofi: Honoraria; Jazz Pharmaceuticals: Honoraria. Chevallier:Daiichi Sankyo: Honoraria; Incyte: Consultancy, Honoraria; Jazz Pharmaceuticals: Honoraria.
Iris type:
1.1 Articolo in rivista
List of contributors:
Robin, M.; Wang, J.; Koster, L.; Beelen, D. W.; Bornhauser, M.; Kroeger, N.; Platzbecker, U.; Finke, J.; Ganser, A.; Blaise, D.; Ciceri, F.; Maertens, J.; Labussiere-Wallet, H.; Chevallier, P.; Passweg, J. R.; Cornelissen, J. J.; Milpied, N.; Charbonnier, A.; Bonifazi, F.; de Wreede, L. C.; Hayden, P.; Scheid, C.; Yakoub-Agha, I.
Published in: